Compliance with the faecal calprotectin test in patients with inflammatory bowel disease

Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy

(2016) Rocio Ferreiro-Iglesias et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Minor Adverse Events Postcolonoscopy

(2016) Catherine Dubé   Canadian Journal of Gastroenterology and Hepatology

A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases

(2015) Eleni Vangeli et al.   ADVANCES IN THERAPY

C-Reactive Protein, Fecal Calprotectin and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis

(2015) Mahmoud H Mosli et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn’s Disease

(2015) Gilles Boschetti et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

(2015) L Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery

(2015) Emily K. Wright et al.   GASTROENTEROLOGY

Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review

(2015) Fanny Depont et al.   PLoS One

Clinical Utility of Fecal Biomarkers for the Diagnosis and Management of Inflammatory Bowel Disease

(2014) Uri Kopylov et al.   INFLAMMATORY BOWEL DISEASES

Meta-analysis

(2014) Jin-Feng Lin et al.   INFLAMMATORY BOWEL DISEASES

A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease

(2013) G. D. Naismith et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring

(2013) Jose-Manuel Benitez et al.   GUT

Adherence to Anti-TNF Therapy in Inflammatory Bowel Diseases

(2013) Anthony Lopez et al.   INFLAMMATORY BOWEL DISEASES

Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy

(2013) Martine De Vos et al.   INFLAMMATORY BOWEL DISEASES

European evidence based consensus for endoscopy in inflammatory bowel disease

(2013) Vito Annese et al.   Journal of Crohns & Colitis

Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial

(2012) Paul Rutgeerts et al.   GASTROENTEROLOGY

Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies

(2012) Ren Mao et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

(2012) Geert DʼHaens et al.   INFLAMMATORY BOWEL DISEASES

The Impact of Adherence to Screening Guidelines and of Diabetes Clinics Referral on Morbidity and Mortality in Diabetes

(2012) Carlo Giorda et al.   PLoS One

Organized colorectal cancer screening programmes

(2011) Jérôme Viguier et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease

(2011) Laurent Peyrin-Biroulet et al.   Journal of Crohns & Colitis

Factors Associated With Non-Adherence to Oral Medication for Inflammatory Bowel Disease: A Systematic Review

(2009) C A Jackson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

(2009) Javier P. Gisbert et al.   INFLAMMATORY BOWEL DISEASES

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease

(2009) Fabian Schnitzler et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin variability in Crohnʼs disease

(2009) Bjrn Moum et al.   INFLAMMATORY BOWEL DISEASES

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

(2008) Geert D'Haens et al.   LANCET

Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices

(2007) Jost Langhorst et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY